secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLOBUS MEDICAL INC (GMED)
CIK:        0001237831
Form:       8-K
Filed at:   2026-06-04T20:11:31+00:00
Accession:  0001628280-26-040784
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Globus Medical shareholders approve 1M share increase to equity plan, re-elect directors
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2021 Equity Incentive Plan, increasing authorized shares by 1,000,000 to 12,000,000.
- Keith Pfeil and Robert A. Douglas re-elected as Class II directors with substantial majority support.
- Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2026.
- Non-binding advisory vote on 2025 executive compensation passed with 316M for vs. 5.2M against.
- No other matters were submitted to stockholders at the June 3, 2026 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/0001628280-26-040784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1237831/000162828026040784/gmed-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-040784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer